Part three of the trial will involve patients at higher risk of cardiovascular disease due to obesity and elevated CRP levels ...

Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...

The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its new drug ...

Current Pharmaceutical Analysis (CPA) invites applications for its Young Editorial Board. Candidates with ≥3 high-impact first/corresponding-author papers, an h-index ≥12, or prior IF>10 publications ...

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, ...

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced the publication of two new peer-reviewed articles detailing nonclinical data supporting the therapeutic potential of its ...

New approaches reflective of individual responses are required to monitor immunosuppressive therapy and to improve its safety and efficacy. This article reviews some of these approaches.

RET (rearrangement during transfection) is a transmembrane glycoprotein receptor tyrosine kinase. In pathological conditions, the RET mutation, gene fusion, and overexpression result in aberrant RET ...